SINOCELLTECH GROUP LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.6 CNY | -0.27% |
|
-2.57% | -9.78% |
| 04-25 | Sinocelltech Group Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-18 | Sinocelltech Forecasts Return to Profit in Q1 | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 26,987 | 23,990 | 21,643 | - | - |
| Enterprise Value (EV) 1 | 26,987 | 23,990 | 21,643 | 21,643 | 21,643 |
| P/E ratio | -50.9 x | -60.5 x | 77.1 x | 40.5 x | - |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 12.7 x | 7.95 x | 6.22 x | - |
| EV / Revenue | - | 12.7 x | 7.95 x | 6.22 x | - |
| EV / EBITDA | - | 225 x | 37.7 x | 23.6 x | - |
| EV / FCF | - | -27 x | -24.2 x | -34.2 x | - |
| FCF Yield | - | -3.7% | -4.14% | -2.92% | - |
| Price to Book | - | -39.9 x | -68.5 x | 99.2 x | - |
| Nbr of stocks (in thousands) | 445,336 | 445,336 | 445,336 | - | - |
| Reference price 2 | 60.60 | 53.87 | 48.60 | 48.60 | 48.60 |
| Announcement Date | 23-02-23 | 24-02-23 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 1,887 | 2,721 | 3,477 | - |
| EBITDA 1 | - | 106.6 | 574 | 916 | - |
| EBIT 1 | - | -20.64 | 792 | 1,098 | - |
| Operating Margin | - | -1.09% | 29.11% | 31.58% | - |
| Earnings before Tax (EBT) 1 | - | -396.8 | 282 | 560 | - |
| Net income 1 | -519 | -396 | 283 | 533 | - |
| Net margin | - | -20.98% | 10.4% | 15.33% | - |
| EPS 2 | -1.190 | -0.8900 | 0.6300 | 1.200 | - |
| Free Cash Flow 1 | - | -888.7 | -895 | -632 | - |
| FCF margin | - | -47.09% | -32.89% | -18.18% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 23-02-23 | 24-02-23 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | -889 | -895 | -632 | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | -14.6% | 8.8% | 12.5% | - |
| Assets 1 | - | 2,719 | 3,216 | 4,264 | - |
| Book Value Per Share 2 | - | -1.350 | -0.7100 | 0.4900 | - |
| Cash Flow per Share 2 | - | -0.8600 | 0.5800 | 1.490 | - |
| Capex 1 | - | 505 | 503 | 410 | - |
| Capex / Sales | - | 26.78% | 18.49% | 11.79% | - |
| Announcement Date | 23-02-23 | 24-02-23 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
48.6
CNY
Average target price
65
CNY
Spread / Average Target
+33.74%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.78% | 2.99B | |
| +5.33% | 111B | |
| +12.11% | 106B | |
| -12.56% | 22.24B | |
| -3.38% | 21.25B | |
| -5.80% | 18.97B | |
| -35.21% | 18.52B | |
| -10.86% | 16.81B | |
| +37.57% | 12.54B | |
| -26.24% | 8.09B |
- Stock Market
- Equities
- 688520 Stock
- Financials Sinocelltech Group Limited
